Management of Acute Lip Swelling
For a patient with isolated lip swelling since Saturday, immediately assess for airway involvement and administer intramuscular epinephrine 0.3 mg, IV diphenhydramine 50 mg, IV methylprednisolone 125 mg, and an H2-blocker, as this presentation suggests histamine-mediated angioedema until proven otherwise. 1
Immediate Airway Assessment (First Priority)
- Evaluate immediately for voice changes, difficulty swallowing, stridor, or respiratory distress, as angioedema can progress unpredictably to involve the oropharynx and larynx, even with isolated lip involvement 1, 2
- Position the patient upright and apply high-flow oxygen if any signs of airway compromise are present 2
- Laryngeal involvement carries approximately 30% historical mortality and requires continuous monitoring in a facility capable of emergency intubation 2
Determine Angioedema Type
- Check immediately for the presence or absence of urticaria (hives) and itching to distinguish histamine-mediated from bradykinin-mediated angioedema 1, 3
- Urticaria is present in approximately 50% of histamine-mediated cases and strongly suggests allergic angioedema 1, 3
- Ask specifically about ACE inhibitor use, as ACE inhibitor-induced angioedema accounts for 30-40% of emergency department presentations and will NOT respond to standard allergy treatments 4
Initial Pharmacologic Treatment
For Presumed Histamine-Mediated Angioedema (with urticaria/itching):
- Epinephrine 0.3 mg intramuscularly (0.3 mL of 1:1000 solution) - this is first-line therapy 1, 2, 5
- Diphenhydramine 50 mg IV 1
- Methylprednisolone 125 mg IV 1
- Ranitidine 50 mg IV or famotidine 20 mg IV (H2-blocker) 1
For Bradykinin-Mediated Angioedema (no urticaria, on ACE inhibitor, or non-responsive to above):
- Discontinue ACE inhibitor permanently if applicable 1
- Icatibant 30 mg subcutaneously OR plasma-derived C1-inhibitor concentrate 1000-2000 units IV 1, 2
- Do NOT use epinephrine, antihistamines, or corticosteroids - these are completely ineffective and delay appropriate therapy 2
Observation and Monitoring
- Observe for at least 2-4 hours after symptom resolution for patients with mild symptoms who respond to treatment 1
- Monitor for biphasic reactions, which can occur up to 6 hours after initial presentation 1
- Any oropharyngeal involvement mandates prolonged observation in a facility capable of airway management 1, 2
Common Pitfalls to Avoid
- Do not assume isolated lip swelling is benign - airway progression can be unpredictable and rapid 1, 2
- Do not treat bradykinin-mediated angioedema with standard allergy medications - this wastes critical time and provides no benefit 2
- Do not discharge without ensuring complete symptom resolution and providing emergency action planning 1
Discharge Planning (Only After Symptom Resolution)
- Prescribe an epinephrine auto-injector for future episodes 1
- Provide written emergency action plan 1
- Document permanent contraindication to all ACE inhibitors if ACE inhibitor-induced angioedema was diagnosed 1
- Arrange allergy/immunology follow-up for identification of triggers 3